IPF treatment

Stockholm, Sweden – April 22, 2026 In a significant advancement for respiratory therapeutics, Vicore Pharma has announced the successful...

MUMBAI, India and WARREN, N.J., April 3, 2026 Cipla USA Inc., a subsidiary of Cipla Limited, has received final...

NEW YORK, April 2, 2026 PureTech Health plc has announced the publication of its Phase 2b ELEVATE IPF trial...